Gabelli Funds LLC Has $5.40 Million Position in Mylan (MYL)
Gabelli Funds LLC cut its holdings in Mylan (NASDAQ:MYL) by 7.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 127,600 shares of the company’s stock after selling 10,000 shares during the quarter. Gabelli Funds LLC’s holdings in Mylan were worth $5,399,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. Pzena Investment Management LLC raised its holdings in Mylan by 84.1% during the third quarter. Pzena Investment Management LLC now owns 22,721,384 shares of the company’s stock worth $712,770,000 after purchasing an additional 10,381,697 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. acquired a new position in Mylan during the fourth quarter worth $137,023,000. Schroder Investment Management Group raised its holdings in Mylan by 74.7% during the third quarter. Schroder Investment Management Group now owns 3,026,172 shares of the company’s stock worth $93,388,000 after purchasing an additional 1,294,400 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in Mylan by 70.8% during the third quarter. Russell Investments Group Ltd. now owns 2,584,880 shares of the company’s stock worth $81,079,000 after purchasing an additional 1,071,089 shares during the last quarter. Finally, Jennison Associates LLC acquired a new position in Mylan during the fourth quarter worth $40,769,000. Hedge funds and other institutional investors own 75.56% of the company’s stock.
Several brokerages recently issued reports on MYL. BidaskClub cut Mylan from a “buy” rating to a “hold” rating in a report on Saturday, February 3rd. Susquehanna Bancshares reaffirmed a “positive” rating and set a $55.00 price objective (up from $47.00) on shares of Mylan in a report on Thursday, January 25th. Deutsche Bank set a $50.00 price objective on Mylan and gave the stock a “buy” rating in a report on Wednesday, January 24th. TheStreet raised Mylan from a “c” rating to a “b-” rating in a report on Wednesday, January 17th. Finally, Wells Fargo & Co set a $43.00 price objective on Mylan and gave the stock a “hold” rating in a report on Thursday, January 18th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $44.65.
Mylan (NASDAQ MYL) opened at $39.28 on Monday. Mylan has a 1-year low of $29.39 and a 1-year high of $47.82. The firm has a market capitalization of $21,071.22, a price-to-earnings ratio of 8.36, a PEG ratio of 1.06 and a beta of 1.35. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.46 and a quick ratio of 0.95.
COPYRIGHT VIOLATION WARNING: This story was first reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.watchlistnews.com/gabelli-funds-llc-has-5-40-million-position-in-mylan-myl/1860911.html.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.